Personal information

Breast Cancer, Medical Oncology, Translational Research
Australia

Biography

I am a medical oncologist and researcher with a focus on breast cancer research and treatment. I completed my medical and oncology training, and doctoral research in Melbourne. Findings from my PhD research under the mentorship of Geoffrey Lindeman and Jane Visvader at the Walter and Eliza Hall Institute, had a major impact on the identification of the culprit cells in carriers of the BRCA1 mutant gene, a hereditary breast cancer syndrome. I subsequently furthered my research and clinical training at the Dana-Farber Cancer Institute and Harvard Medical School under the mentorship of Eric Winer and Myles Brown, both internationally acclaimed leaders in breast cancer research and clinical trials, through fellowships from the Fulbright Foundation, National Health and Medical Research Council of Australia, and Royal Australasian College of Physicians.

I currently oversee the breast oncology services at the Kinghorn Cancer Centre, St Vincent’s Hospital in Sydney. I also head the Connie Johnson breast cancer research laboratory at the Garvan Institute of Medical Research. Our laboratory performs clinically focused laboratory research, including the establishment of patient-derived breast tumour xenografts in mice, the evaluation of novel therapies in these preclinical breast cancer models and the comparative study between normal and breast cancer tissue. Another major focus of my group is hormone receptors (such as the estrogen and androgen receptors) in breast tumours, specifically to identify ways to sensitize these cancer cells to endocrine therapies. Our research is funded through Cancer Australia, and the National Breast Cancer, Love Your Sister, Ramaciotti and Garvan foundations.

I also seek to improve healthcare more globally. At a local level, I volunteered as a physician to asylum seekers without access to Medicare. I currently work with the Asha Kiran Hospital in Orissa, India, on a longer-term strategy of expertise transfer and partnership with local doctors.

Activities

Employment (6)

University of New South Wales: Sydney, NSW, AU

2021-01-01 to present | Clinical Academic/Professor of Medicine (Faculty of Medicine)
Employment
Source: Self-asserted source
Elgene Lim

Saint Vincent's Hospital Sydney: Darlinghurst, NSW, AU

2015-08-01 to present | Senior Staff Specialist (The Kinghorn Cancer Centre)
Employment
Source: Self-asserted source
Elgene Lim

Garvan Institute of Medical Research: Darlinghurst, NSW, AU

2015-08-01 to present | Lab Head (Connie Johnson Breast Cancer Research Group)
Employment
Source: Self-asserted source
Elgene Lim

Olivia Newton-John Cancer Research Institute: Heidelberg, VIC, AU

2014-02-01 to 2015-07-31 | Group Leader (Translational Breast Cancer Research Laboratory)
Employment
Source: Self-asserted source
Elgene Lim

Olivia Newton-John Cancer Centre at Austin Health: Heidelberg, VIC, AU

2014-02-01 to 2015-07-31 | Staff Oncologist (Medical Oncology)
Employment
Source: Self-asserted source
Elgene Lim

Dana Farber Cancer Institute: Boston, MA, US

2010-03-20 to 2014-01-31 | Breast Oncology Fellow (Women's Cancers Division)
Employment
Source: Self-asserted source
Elgene Lim

Education and qualifications (3)

Royal Australasian College of Physicians: Melbourne, VIC, AU

2006-12-01 to present | FRACP
Education
Source: Self-asserted source
Elgene Lim

Walter and Eliza Hall Institute of Medical Research: Melbourne, VIC, AU

2006-02-01 to 2010-03-01 | PhD
Education
Source: Self-asserted source
Elgene Lim

University of Melbourne: Melbourne, VIC, AU

1990-03-01 to 1995-12-31 | MBBS
Education
Source: Self-asserted source
Elgene Lim

Funding (16)

A combinatorial drug strategy to target lethal forms of breast cancer

2020-01 to 2023-12 | Grant
National Health and Medical Research Council (ACT, ACT, AU)
GRANT_NUMBER:

APP 1186647

Source: Self-asserted source
Elgene Lim

The establishment of clinically relevant breast cancer preclinical models to identify therapeutic vulnerabilities in cancer

2019-06 to 2021-05 | Grant
Love Your Sister (Melbourne, VIC, AU)
Source: Self-asserted source
Elgene Lim

Therapeutic targeting of dual CDK4/6 inhibitor and endocrine resistant breast cancer

2019-01 to 2022-12 | Grant
National Breast Cancer Foundation (NSW, NSW, AU)
GRANT_NUMBER:

IIRS 19-054

Source: Self-asserted source
Elgene Lim

Targeting the p53 pathway in the age of CDK4/6 inhibitor resistant ER+ breast cancer

2019-01 to 2021-12 | Grant
National Breast Cancer Foundation (NSW, NSW, AU)
GRANT_NUMBER:

IIRS 19-053

Source: Self-asserted source
Elgene Lim

The Breast Cancer Cell Atlas

2019-01 to 2021-12 | Grant
National Breast Cancer Foundation (NSW, NSW, AU)
GRANT_NUMBER:

IIRS-19-106

Source: Self-asserted source
Elgene Lim

A comprehensive approach to identifying and evaluating new therapies for patients with treatment-resistant breast cancer.

2019-01 to 2020-12 | Grant
Balnave's Foundation (Sydney, NSW, AU)
Source: Self-asserted source
Elgene Lim

Transforming endocrine therapy for breast and prostate cancer.

2018-06 to 2021-06 | Grant
National Breast Cancer Foundation and Movember (SYDNEY, NSW, AU)
GRANT_NUMBER: Linkage Grant 2018
Source: Self-asserted source
Elgene Lim

Endowed Chair

2018-01 to 2027-12 | Award
National Breast Cancer Foundation (NSW, NSW, AU)
GRANT_NUMBER:

EC17-02

Source: Self-asserted source
Elgene Lim

Centre for Translational Breast Cancer Research (TransBCR): delivering laboratory discoveries to the clinic.

2018-01 to 2022-12 | Grant
National Health and Medical Research Council (ACT, ACT, AU)
GRANT_NUMBER:

APP 1153049

Source: Self-asserted source
Elgene Lim

Discovering new therapeutic strategies for metastatic triple negative breast cancer at cellular resolution

2018-01 to 2020-12 | Grant
National Breast Cancer Foundation (NSW, NSW, AU)
GRANT_NUMBER:

IIRS-18-069

Source: Self-asserted source
Elgene Lim

Pushing AR toward better outcomes in breast and prostate cancers

2018-01 to 2020-12 | Grant
National Health and Medical Research Council (ACT, ACT, AU)
GRANT_NUMBER: APP 1145777
Source: Self-asserted source
Elgene Lim

Development of a novel and highly selective CDK4/6 inhibitor for treating cancer.

2017-01 to 2020-12 | Grant
National Health and Medical Research Council (ACT, ACT, AU)
GRANT_NUMBER:

APP 1135682

Source: Self-asserted source
Elgene Lim

Four dimensional epigenome remodelling: implications for endocrine resistance in breast cancer.

2017-01 to 2020-12 | Grant
National Health and Medical Research Council (ACT, ACT, AU)
GRANT_NUMBER: APP 1128916
Source: Self-asserted source
Elgene Lim

Targeting the Oncoprotein MDMX as a Novel Treatment for Triple Negative Breast Cancer.

2017-01 to 2020-12 | Grant
National Health and Medical Research Council (ACT, ACT, AU)
GRANT_NUMBER: App 1123057
Source: Self-asserted source
Elgene Lim

The clinical significance of sex hormone crosstalk in estrogen receptor positive breast cancer.

2017-01 to 2019-12 | Grant
National Health and Medical Research Council (ACT, ACT, AU)
GRANT_NUMBER: APP 1130077
Source: Self-asserted source
Elgene Lim

Selective activation of androgen receptor to treat estrogen receptor positive breast cancer.

2015-01 to 2017-12 | Grant
National Health and Medical Research Council (ACT, ACT, AU)
GRANT_NUMBER: APP 1084416
Source: Self-asserted source
Elgene Lim

Peer review (4 reviews for 3 publications/grants)

Review activity for Breast cancer research (2)
Review activity for Nature cancer. (1)
Review activity for NPJ breast cancer. (1)